Cargando…
Correction to: Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
Autores principales: | Citrome, Leslie, Risinger, Robert, Rajachandran, Lavanya, Robison, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859843/ https://www.ncbi.nlm.nih.gov/pubmed/36315340 http://dx.doi.org/10.1007/s12325-022-02350-8 |
Ejemplares similares
-
Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed
por: Citrome, Leslie, et al.
Publicado: (2022) -
Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm
por: Citrome, Leslie, et al.
Publicado: (2019) -
Sublingual Dexmedetomidine for the Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder
por: Smith, Colin M., et al.
Publicado: (2023) -
Benefit–Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm
por: Citrome, Leslie, et al.
Publicado: (2021) -
COVID-19 vaccination in pregnancy—number needed to vaccinate to avoid harm
por: Magee, Laura A, et al.
Publicado: (2021)